title: p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
abstract: The tumor suppressor p53 gene plays a crucial role in preventing carcinogenesis through its ability to induce cell cycle arrest and apoptosis following DNA damage and oncogene activation. A guanine (G)/cytosine (C) common single nucleotide polymorphism (SNP) at second position of codon 72 in exon 4 of p53 gene determines a arginine (Arg) to proline (Pro) (Arg72Pro) aminoacidic substitution within the proline-rich domain of p53 protein. Arg72 and Pro72 allele are different from a biochemical and biological point of view and many reports suggest that they can modulate individual cancer susceptibility. To determine the association of the p53 Arg72Pro polymorphism with the risk of hepatocellular carcinoma (HCC) development in a Turkish population, a hospital-based case-control study was designed consisting of 119 subjects with HCC and 119 cancer-free control subjects matched for age, gender, smoking and alcohol status. The genotype frequency of the p53 Arg72Pro polymorphism was determined by using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. Our data shows that the Pro/Pro genotype of the p53 Arg72Pro polymorphism is associated with increased risk of HCC development in this Turkish population (OR = 3.20, 95% CI: 1.24-8.22, P = 0.02). Furthermore, according to stratified analysis, a significant association was observed between the homozygote Pro/Pro genotype and HCC risk in the subgroups of male gender (OR = 3.01, 95% CI: 1.14-7.97, P = 0.03) and patients with hepatitis B virus (HBV)-related HCC (OR = 4.04, 95% CI: 1.46-11.15, P = 0.007). Because our results suggest for the first time that the Pro/Pro homozygote of p53 Arg72Pro polymorphism may be a genetic susceptibility factor for HCC (especially in the male gender and HBV-infected patients) in the Turkish population, further independent studies are required to validate our findings in a larger series, as well as in patients of different ethnic origins.
authors: Department of Internal Medicine, Faculty of Medicine, Çukurova University, 01330 Adana, Turkey.
authors: Ahmet Taner
authors: AT
authors: Sümbül
authors: Hikmet
authors: H
authors: Akkız
authors: Süleyman
authors: S
authors: Bayram
authors: Aynur
authors: A
authors: Bekar
authors: Ersin
authors: E
authors: Akgöllü
authors: Macit
authors: M
authors: Sandıkçı
references: Nat Genet. 2003 Mar;33(3):357-65
references: 12567188
references: World J Gastroenterol. 2005 Jan 14;11(2):289-92
references: 15633234
references: Hum Mutat. 2003 Mar;21(3):201-16
references: 12619106
references: Nature. 1998 May 21;393(6682):229-34
references: 9607760
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Br J Surg. 1973 Aug;60(8):646-9
references: 4541913
references: Gastroenterology. 2007 Jun;132(7):2557-76
references: 17570226
references: Nat Rev Cancer. 2005 Nov;5(11):845-56
references: 16239904
references: J Hepatol. 2001 Sep;35(3):421-30
references: 11592607
references: Ann N Y Acad Sci. 2003 Dec;1010:764-70
references: 15033824
references: Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15335-40
references: 8986812
references: Carcinogenesis. 2008 Jun;29(6):1192-6
references: 18390844
references: Cell. 1997 Feb 7;88(3):323-31
references: 9039259
references: Int J Cancer. 2011 Jan 15;128(2):412-7
references: 20309940
references: Cell Death Differ. 2006 Jun;13(6):916-20
references: 16557270
references: Oncogene. 2006 Jun 15;25(25):3489-500
references: 16462765
references: Hepatology. 1999 Mar;29(3):697-702
references: 10051470
references: Gene. 1988 Oct 30;70(2):245-52
references: 2905688
references: Cancer Lett. 2005 Nov 8;229(1):77-83
references: 15979781
references: Nat Rev Cancer. 2006 Sep;6(9):674-87
references: 16929323
references: Mol Cell Biochem. 2011 Jan;347(1-2):201-8
references: 21042835
references: Int J Cancer. 2004 Jan 10;108(2):196-9
references: 14639602
references: Cancer Lett. 2003 Apr 25;193(2):199-205
references: 12706878
references: Mol Cell Biol. 1986 Dec;6(12):4650-6
references: 3025664
references: Mol Cell Biol. 1999 Feb;19(2):1092-100
references: 9891044
references: Liver. 1994 Apr;14(2):98-102
references: 7515142
references: Mol Cell Biol. 1987 Feb;7(2):961-3
references: 3547088
references: Clin Cancer Res. 2003 Oct 15;9(13):4860-4
references: 14581358
references: Hum Hered. 1994 Sep-Oct;44(5):266-70
references: 7927355
references: Cancer Lett. 2004 May 10;208(1):75-9
references: 15105048
references: J Viral Hepat. 2010 Sep;17(9):668-74
references: 20002563
references: Gastroenterology. 2000 Jun;118(6):1039-44
references: 10833478
references: Oncogene. 2007 Feb 26;26(9):1317-23
references: 17322917
references: Cancer Res. 1994 Sep 15;54(18):4855-78
references: 8069852
references: J Cell Sci. 2001 Dec;114(Pt 23):4139-40
references: 11739646
references: Oncol Rep. 2004 May;11(5):1115-20
references: 15069555
references: Oncogene. 1997 Aug 18;15(8):887-98
references: 9285684
references: Nat Rev Cancer. 2009 Feb;9(2):95-107
references: 19165225
references: Carcinogenesis. 1994 Apr;15(4):583-7
references: 7908608
references: Science. 1991 Jul 5;253(5015):49-53
references: 1905840
references: Science. 2004 Feb 13;303(5660):1010-4
references: 14963330
references: Cancer Res. 2001 Dec 15;61(24):8718-22
references: 11751390
references: Hepatol Res. 2007 Sep;37(9):748-54
references: 17573955
references: Science. 2007 Jul 6;317(5834):121-4
references: 17615358
references: Eur J Cancer. 1999 Feb;35(2):226-30
references: 10448264
references: Nat Cell Biol. 2004 May;6(5):443-50
references: 15077116